ReP USP - Resultado da busca

Trabalho de evento-resumo
Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings (2012)
Azevedo, A.; Prado, A. F.; Pernomian, L.; Tanus-Santos, José Eduardo; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda
Source: Late Abstracts. Conference titles: European Congress of Pharmacology (EPHAR). Unidades: FCFRP, FMRP, FORP
Subjects: METALOPROTEINASES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, A. et al. Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings. 2012, Anais.. Granada: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2012. . Acesso em: 09 nov. 2024.
APA
Azevedo, A., Prado, A. F., Pernomian, L., Tanus-Santos, J. E., Bendhack, L. M., & Gerlach, R. F. (2012). Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings. In Late Abstracts. Granada: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Azevedo A, Prado AF, Pernomian L, Tanus-Santos JE, Bendhack LM, Gerlach RF. Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings. Late Abstracts. 2012 ;[citado 2024 nov. 09 ]
Vancouver
Azevedo A, Prado AF, Pernomian L, Tanus-Santos JE, Bendhack LM, Gerlach RF. Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings. Late Abstracts. 2012 ;[citado 2024 nov. 09 ]
Artigo de periodico
Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability (2012)
Castro, Michele M.; Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle A.; Rodrigues, Gerson J.; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Nitric Oxide. Unidades: FCFRP, FORP, FMRP
Subjects: HIPERTENSÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR) (EFEITOS), ESTRESSE OXIDATIVO, NEUTRÓFILOS (TESTES;TÉCNICAS IN VITRO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Michele M. et al. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide, v. 26, n. 3, p. 162-168, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2012.01.009. Acesso em: 09 nov. 2024.
APA
Castro, M. M., Rizzi, E., Ceron, C. S., Guimarães, D. A., Rodrigues, G. J., Bendhack, L. M., et al. (2012). Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide, 26( 3), 162-168. doi:10.1016/j.niox.2012.01.009
NLM
Castro MM, Rizzi E, Ceron CS, Guimarães DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability [Internet]. Nitric Oxide. 2012 ; 26( 3): 162-168.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.niox.2012.01.009
Vancouver
Castro MM, Rizzi E, Ceron CS, Guimarães DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability [Internet]. Nitric Oxide. 2012 ; 26( 3): 162-168.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.niox.2012.01.009
Trabalho de evento-resumo
Temporal evaluation of 2K1C model of renovascular hypertension: metalloproteinases and oxidative stress (2010)
Ceron, C. S.; Rizzi, E.; Oliveira, Ana Maria de; Guimarães, D. A.; Cau, S. B. A.; Marçal, D. M. O.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Programa. Conference titles: Congresso Brasileiro de Farmacologia e Terapêutica Experimental. Unidades: FCFRP, FORP, FMRP
Subjects: METALOPROTEINASES, ESTRESSE OXIDATIVO, PRESSÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERON, C. S. et al. Temporal evaluation of 2K1C model of renovascular hypertension: metalloproteinases and oxidative stress. 2010, Anais.. Ribeirão Preto: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 09 nov. 2024.
APA
Ceron, C. S., Rizzi, E., Oliveira, A. M. de, Guimarães, D. A., Cau, S. B. A., Marçal, D. M. O., et al. (2010). Temporal evaluation of 2K1C model of renovascular hypertension: metalloproteinases and oxidative stress. In Programa. Ribeirão Preto: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Ceron CS, Rizzi E, Oliveira AM de, Guimarães DA, Cau SBA, Marçal DMO, Gerlach RF, Tanus-Santos JE. Temporal evaluation of 2K1C model of renovascular hypertension: metalloproteinases and oxidative stress. Programa. 2010 ;[citado 2024 nov. 09 ]
Vancouver
Ceron CS, Rizzi E, Oliveira AM de, Guimarães DA, Cau SBA, Marçal DMO, Gerlach RF, Tanus-Santos JE. Temporal evaluation of 2K1C model of renovascular hypertension: metalloproteinases and oxidative stress. Programa. 2010 ;[citado 2024 nov. 09 ]
Artigo de periodico
Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities (2009)
Jacob-Ferreira, Anna L. B.; Passos, Carlos J. S.; Jordão, Alceu A.; Fillion, Myriam; Mergler, Donna; Lemire, Mélanie; Gerlach, Raquel Fernanda; Barbosa Júnior, Fernando; Tanus-Santos, José Eduardo
Source: Basic and Clinical Pharmacology and Toxicology. Unidades: FORP, FCFRP, FMRP
Subjects: METALOPROTEINASES, ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES, MERCÚRIO (ELEMENTO QUÍMICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOB-FERREIRA, Anna L. B. et al. Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities. Basic and Clinical Pharmacology and Toxicology, v. 105, n. 4, p. 281-288, 2009Tradução . . Acesso em: 09 nov. 2024.
APA
Jacob-Ferreira, A. L. B., Passos, C. J. S., Jordão, A. A., Fillion, M., Mergler, D., Lemire, M., et al. (2009). Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities. Basic and Clinical Pharmacology and Toxicology, 105( 4), 281-288.
NLM
Jacob-Ferreira ALB, Passos CJS, Jordão AA, Fillion M, Mergler D, Lemire M, Gerlach RF, Barbosa Júnior F, Tanus-Santos JE. Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities. Basic and Clinical Pharmacology and Toxicology. 2009 ; 105( 4): 281-288.[citado 2024 nov. 09 ]
Vancouver
Jacob-Ferreira ALB, Passos CJS, Jordão AA, Fillion M, Mergler D, Lemire M, Gerlach RF, Barbosa Júnior F, Tanus-Santos JE. Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities. Basic and Clinical Pharmacology and Toxicology. 2009 ; 105( 4): 281-288.[citado 2024 nov. 09 ]
Artigo de periodico
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats (2008)
Martinez, Marcio L. L.; Rizzi, Elen; Castro, Michele M.; Fernandes, Karla; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: European Journal of Pharmacology. Unidades: FMRP, FCFRP, FORP
Subjects: DIABETES MELLITUS, METALOPROTEINASES, DOENÇAS CARDIOVASCULARES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 09 nov. 2024.
APA
Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007
NLM
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
Vancouver
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em